Raise closed, search for fresh raises on Seedstage

Akron, OH

Advancing innovative wound care solutions to enhance healing and patient outcomes.

• Mission: Developing innovative wound care solutions using proprietary biopolymer technology to enhance healing and improve patient outcomes, particularly for chronic wounds.  
• Innovation: Introducing OXAID™, an oxygenating, moist, and antimicrobial dressing that creates an optimal healing environment, designed to accelerate the recovery of chronic wounds.  
• Healthcare Impact: Addressing significant challenges in wound care by providing cost-effective, user-friendly products that enhance healing, reduce complications, and improve quality of life for patients.  
• Funding Uses: Supporting further product development, regulatory affairs, and operational needs, including biocompatibility testing to ensure safety and efficacy in various medical settings.  
• Market Opportunity: Targeting medical professionals and institutions with advanced wound management solutions, positioning O2 RegenTech as a leader in the evolving wound care market.  
• Future Vision: Expanding the reach of their wound care technology to reduce the burden on healthcare systems while improving patient care and recovery outcomes.  

O2 RegenTech is focused on developing innovative wound care solutions that leverage proprietary biopolymer technology. Their flagship product, OXAID™, serves as an oxygenating, moist, and antimicrobial dressing specifically designed to facilitate the healing of chronic wounds.

The company aims to address significant challenges in wound care by providing cost-effective and user-friendly products that enhance patient outcomes. Through this fundraising initiative, O2 RegenTech seeks to secure capital that will support further product development, regulatory affairs, and operational needs, including biocompatibility testing.

By advancing their wound care technology, O2 RegenTech aspires to make a meaningful impact in the healthcare sector, particularly for patients suffering from chronic wounds, thereby improving their quality of life and reducing the burden on healthcare systems.

Company Info

OXAID offers an oxygenating and antimicrobial wound dressing designed to enhance healing.

OXAID is a specialized product designed for wound care, featuring an oxygenating, moist, and antimicrobial dressing. This innovative dressing aims to enhance the healing process by providing a conducive environment for wound recovery. The product is intended for use in various medical settings, offering benefits such as moisture retention and infection prevention. OXAID is positioned within the healthcare market, targeting medical professionals and institutions that prioritize advanced wound management solutions. The company also has a net capital Reg CF offering currently live, indicating an interest in expanding its reach and funding for further development. OXAID represents a modern approach to wound care, focusing on both efficacy and safety in the healing process.